Efficacy and Safety Study of Bendamustine With or Without Rituximab in Chronic Lymphoproliferative Disorders
NCT01832597
·
clinicaltrials.gov ↗
COMPLETED
Status
109
Enrollment
OTHER
Sponsor class
Conditions
Chronic Lymphocytic Leukaemia
Sponsor
Gruppo Italiano Studio Linfomi